send to a friend by email

BPC posts net income of $5.48 million in 2013

2014-02-17

According to Birzeit Pharmaceuticals Company ( BPC) data for year-end preliminary financial statements for year 2013, net profit after taxes reached 5,480,204 USD, compared with a net profit after taxes of 4,785,914 USD in the audited data for 2012, a net increase of 14.5%. Total assets of the company reached 64,753,100 USD as of December 31^st, 2013, compared to total assets of 59,958,678 USD as of December 31^st, 2012, a net increase of 8.0%. Total liabilities of the company reached 12,828,330 USD as of December 31^st, 2013, compared to total liabilities of 11,736,829 USD as of December 31^st, 2012, a net increase of 9.3%. Net ownership equity of the company reached 51,924,770 USD (including 199,413 USD in Non-controlling interest) as of December 31^st, 2013, compared with a net ownership equity of 48,221,849 USD (including 336,020 USD in Non-controlling interest) as of December 31^st, 2012, a net increase of 7.7%. Furthermore, paid-in capital increased from 18,490,177 USD  on December 31^st, 2012 to 18,502,825 USD  by December 31^st, 2013, an increase of 0.01%.